Home › Companies › FBIO

Fortress Biotech

FBIO Rare disease Lead: Approved ★ Read the deep dive → 8 Biotech Distilled articles ↓

Dermatology Hematology Infectious Disease Metabolic Oncology Cell Protein Small Molecule

Most recent annual filing: 2026-03-31

Catalyst timeline

5 trackedQuarter catalyst calendar →

ATX-04 clenbuterol trial start2026ATX-04 clenbuterol trial start, 2026, routine
Dotinurad Ph3 toplineLate 2026Dotinurad Ph3 topline, Late 2026, material
Triplex Ph2 readoutEnd of 2026Triplex Ph2 readout, End of 2026, notable
MB-109 Ph1 start4Q 2026MB-109 Ph1 start, 4Q 2026, routine
Oaktree debt corporate updateJun 2028Oaktree debt corporate update, Jun 2028, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (12 active programs)

Emrosi

minocycline hydrochloride extended-release capsules · Minocycline Hydrochloride Modified Release Capsules · DFD-29

Rosacea Approved oral

UNLOXCYT

cosibelimab-ipdl

Protein Target: PD-L1

Cutaneous Squamous Cell Carcinoma Approved Sun Pharma NCT04786964

ZYCUBO

copper histidinate injection · copper histidinate · CUTX-101

Menkes Disease Approved intravenous Sentynl Therapeutics

anselamimab

CAEL-101

Protein Target: light chain fibrils

AL Amyloidosis Phase 3

triplex

Protein Target: cytomegalovirus

Cytomegalovirus Infection Phase 2

AJ201

Small Molecule Target: Nrf1, Nrf2, androgen receptor

Undisclosed indication

BAER-101

Small Molecule Target: GABAA α2/3

Undisclosed indication

clenbuterol

ATX-04

Small Molecule Target: β2-adrenergic receptor

Pompe Disease Preclinical Duke University

Amzeeq

Acne Approved

Zilxi

Rosacea Approved

dotinurad

Small Molecule Target: URAT1

Gout Phase 2 oral

MB-109

Cell Target: IL13Rα2

Glioblastoma

Biotech Distilled coverage (8)

2026-10-01 UPDATE: Fortress Biotech (FBIO) - The Lender Got Paid. The Deadline Passed. 🔒 Paid
2026-08-14 UPDATE: Fortress Biotech (FBIO) - The Three Lines I Was Watching All Printed 🔒 Paid
2026-08-13 UPDATE: Fortress Biotech (FBIO) - The Spoke Keeps Printing, The Hub Keeps Discounting 🔒 Paid
2026-07-28 UPDATE: Fortress Biotech (FBIO) - The Free Option Just Got Funded 🔒 Paid
2026-05-15 UPDATE: Fortress Biotech (FBIO) - The Parent Balance Sheet Finally Prints 🔒 Paid
2026-05-14 UPDATE: Fortress Biotech (FBIO) - Journey Hits Positive EBITDA, Emrosi Triples YoY 🔒 Paid
2026-04-27 UPDATE: Fortress Biotech (FBIO) - The PRV Cash Lands, The Covenants Vanish, The Stock Bleeds Anyway 🔒 Paid
2026-02-24 Fortress Biotech (FBIO): Scientific Deep Dive for Lead and Pipeline Products

Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.